Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus.
Mod Rheumatol
; 21(3): 276-81, 2011 Jun.
Article
de En
| MEDLINE
| ID: mdl-21225443
ABSTRACT
To characterize reversible posterior leukoencephalopathy syndrome (RPLS) in systemic lupus erythematosus (SLE) in terms of treatments for resolution and its clinical course, we reviewed 28 cases of RPLS in SLE including our cases in view of the treatment. Of these, 15 cases improved with blood pressure control and 13 required immunosuppressive therapy for activity of SLE presenting neurological manifestations. Patients without immunosuppressants at onset of RPLS more frequently required immunosuppressive therapy to recover it than those precedingly using these agents [31% (4/13) versus 87% (13/15), p = 0.008, chi-square test]. Brain magnetic resonance imaging (MRI) is important for diagnosis of RPLS-SLE in the patient with SLE who develops neurological disturbance and rapidly increasing blood pressure. When 7-day therapy for hypertension and convulsion does not reverse the manifestations, immunosuppressive treatments would be recommended to reverse RPLS.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Vascularite lupique du système nerveux central
/
Imagerie par résonance magnétique de diffusion
/
Leucoencéphalopathie postérieure
Limites:
Adult
/
Female
/
Humans
/
Male
Langue:
En
Journal:
Mod Rheumatol
Année:
2011
Type de document:
Article
Pays d'affiliation:
Japon